Filing Details
- Accession Number:
- 0001209191-22-046900
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 17:32:00
- Reporting Period:
- 2022-07-01
- Accepted Time:
- 2022-08-19 17:32:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-07-01 | 20 | $2.11 | 17,024 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-05 | 27 | $2.18 | 17,051 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-06 | 27 | $2.11 | 17,078 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-07 | 27 | $2.18 | 17,105 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-08 | 27 | $2.21 | 17,132 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-12 | 27 | $2.25 | 17,159 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-14 | 27 | $2.28 | 17,186 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-15 | 27 | $2.23 | 17,213 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-18 | 24 | $2.41 | 17,237 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-19 | 24 | $2.47 | 17,261 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-20 | 24 | $2.52 | 17,285 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-21 | 24 | $2.54 | 17,309 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-22 | 24 | $2.53 | 17,333 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-25 | 24 | $2.48 | 17,357 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-26 | 24 | $2.47 | 17,381 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-27 | 19 | $2.36 | 17,400 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-28 | 24 | $2.28 | 17,424 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-29 | 24 | $2.28 | 17,448 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-01 | 24 | $2.34 | 17,472 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-03 | 12 | $2.45 | 17,484 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-04 | 24 | $2.17 | 17,508 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-05 | 24 | $2.12 | 17,532 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-08 | 26 | $2.19 | 17,558 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-09 | 26 | $2.19 | 17,584 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-10 | 26 | $2.19 | 17,610 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-11 | 26 | $2.46 | 17,636 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-12 | 26 | $2.52 | 17,662 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-15 | 20 | $2.45 | 17,682 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.